Midorikawa Y, Kubota K, Takayama T, Toyoda H, Ijichi M, Torzilli G, Mori M, Makuuchi M
Department of Surgery, Graduate School of Medicine, University of Tokyo, Japan.
Surgery. 1999 Sep;126(3):484-91.
Although hepatic resection is the most reliable treatment for hepatocellular carcinoma, impaired liver function because of cirrhosis or chronic hepatitis contributes to relatively high rates of postoperative complications. We have reviewed a series of hepatectomies at our institution and investigated risk factors for complications after hepatectomy in patients with impaired liver compared with patients with normal liver.
From October 1994 to March 1998, 277 hepatectomies for hepatocellular carcinoma, cholangiocellular carcinoma, metastatic liver tumors, and other hepatic diseases were performed. In an attempt to clarify the safety of hepatectomy for the impaired liver at our institution, we did a comparative study of postoperative complications after hepatectomy in 2 groups: patients with impaired livers (187 hepatectomies) and patients with normal livers (90 hepatectomies).
Of the 277 hepatectomies, bile leakage occurred in 25 patients (16 in impaired livers vs 9 in normal livers), abdominal infection in 45 patients (30 vs 15 patients), wound infection in 13 patients (9 vs 4 patients), pleural effusion in 52 patients (35 vs 17 patients), atelectasis in 26 patients (17 vs 9 patients), pneumonia in 4 patients (3 vs 1 patients), ileus in 6 patients (3 vs 3 patients), intra-abdominal hemorrhage in 3 patients (0 vs 3 patients), and hyperbilirubinemia in 5 patients (4 vs 1 patients). Hepatic insufficiency and hospital death were not experienced in this series. The mean postoperative hospital stay was 22.9 days (23.5 vs 23.1 days), and except for intra-abdominal hemorrhage there was no statistically significant difference between the 2 groups.
Hepatectomy for the impaired liver is now as safe a procedure as for the normal liver, provided the overall guidelines outlined in our algorithm are followed.
尽管肝切除术是肝细胞癌最可靠的治疗方法,但肝硬化或慢性肝炎导致的肝功能受损会使术后并发症发生率相对较高。我们回顾了本机构的一系列肝切除术,并调查了肝功能受损患者与肝功能正常患者肝切除术后并发症的危险因素。
1994年10月至1998年3月,对277例因肝细胞癌、胆管细胞癌、肝转移瘤及其他肝脏疾病行肝切除术。为了明确本机构肝切除术对肝功能受损患者的安全性,我们对两组肝切除术后的并发症进行了对比研究:肝功能受损患者(187例肝切除术)和肝功能正常患者(90例肝切除术)。
277例肝切除术中,25例发生胆漏(肝功能受损组16例,肝功能正常组9例),45例发生腹腔感染(30例vs 15例),13例发生伤口感染(9例vs 4例),52例发生胸腔积液(35例vs 17例),26例发生肺不张(17例vs 9例),4例发生肺炎(3例vs 1例),6例发生肠梗阻(3例vs 3例),3例发生腹腔内出血(0例vs 3例),5例发生高胆红素血症(4例vs 1例)。本系列未发生肝功能不全和医院死亡。术后平均住院时间为22.9天(23.5天vs 23.1天),除腹腔内出血外,两组间无统计学显著差异。
只要遵循我们算法中概述的总体指导原则,肝功能受损患者的肝切除术现在与肝功能正常患者的手术一样安全。